Your browser doesn't support javascript.
loading
Disease-stabilizing treatment based on all-trans retinoic acid and valproic acid in acute myeloid leukemia - identification of responders by gene expression profiling of pretreatment leukemic cells.
Reikvam, Håkon; Hovland, Randi; Forthun, Rakel Brendsdal; Erdal, Sigrid; Gjertsen, Bjørn Tore; Fredly, Hanne; Bruserud, Øystein.
Afiliação
  • Reikvam H; Department of Medicine, Haukeland University Hospital, N-5021, Bergen, Norway. Hakon.Reikvam@med.uib.no.
  • Hovland R; Center for Medical Genetics and Molecular Medicine, Haukeland University Hospital, Bergen, Norway.
  • Forthun RB; Section for Hematology, Institute of Clinical Science, University of Bergen, Bergen, Norway.
  • Erdal S; Center for Medical Genetics and Molecular Medicine, Haukeland University Hospital, Bergen, Norway.
  • Gjertsen BT; Section for Hematology, Institute of Clinical Science, University of Bergen, Bergen, Norway.
  • Fredly H; Section for Hematology, Institute of Clinical Science, University of Bergen, Bergen, Norway.
  • Bruserud Ø; Section for Hematology, Institute of Clinical Science, University of Bergen, Bergen, Norway.
BMC Cancer ; 17(1): 630, 2017 Sep 06.
Article em En | MEDLINE | ID: mdl-28877686

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudo: Diagnostic_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudo: Diagnostic_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article